Key result
Structural analysis of human PDE5A1 revealed dramatic conformational differences in GAF-A upon cGMP binding and identified an inhibitory role for the N-terminal loop in cGMP binding.
Answers are grounded in this paper and cite their sources.
The activity of phosphodiesterase-5 (PDE5) is specific for cGMP and is regulated by cGMP binding to GAF-A in its regulatory domain. To better understand the regulatory mechanism, x-ray crystallographic and biochemical studies were performed on constructs of human PDE5A1 containing the N-terminal phosphorylation segment, GAF-A, and GAF-B. Superposition of this unliganded GAF-A with the previously reported NMR structure of cGMP-bound PDE5 revealed dramatic conformational differences and suggested that helix H4 and strand B3 probably serve as two lids to gate the cGMP-binding pocket in GAF-A. The structure also identified an interfacial region among GAF-A, GAF-B, and the N-terminal loop, which may serve as a relay of the cGMP signal from GAF-A to GAF-B. N-terminal loop 98-147 was physically associated with GAF-B domains of the dimer. Biochemical analyses showed an inhibitory effect of this loop on cGMP binding and its involvement in the cGMP-induced conformation changes.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2010) studied this question. X-ray crystallographic and biochemical studies on human PDE5A1 constructs was evaluated on Conformational changes and cGMP binding mechanisms. Structural analysis of human PDE5A1 revealed dramatic conformational differences in GAF-A upon cGMP binding and identified an inhibitory role for the N-terminal loop in cGMP binding.
Synapse has enriched 10 related papers. Consider them for comparative context: